Buckingham Strategic Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$3.15K Buy
+100
New +$29.4K ﹤0.01% 778

Other funds holding AMGN

Buckingham Strategic Wealth's AMGN Position: Q2 2024 in Review

Buckingham Strategic Wealth reduced its Amgen (AMGN) stake by 1.9% in Q2 2024, selling an estimated $73.7K and leaving 12,765 shares worth $3.99M. The position accounts for 0.04% of the portfolio, ranked #169.

Buckingham Strategic Wealth first reported a position in AMGN in Q2 2013 and has held it in 45 quarters since. The position peaked at $5.05M in Q3 2023. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Buckingham Strategic Wealth held 12,765 shares of Amgen worth $3.99M as of Q2 2024.
  • Buckingham Strategic Wealth sold 251 Amgen shares in Q2 2024, an estimated $73.7K.
  • Amgen made up 0.04% of Buckingham Strategic Wealth's portfolio in Q2 2024, its #169 holding.
  • Buckingham Strategic Wealth first reported a position in Amgen in Q2 2013 and has held it in 45 quarters since.
  • Buckingham Strategic Wealth's Amgen position peaked at $5.05M in Q3 2023.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Buckingham Strategic Wealth's 13F filing for Q2 2024, filed 12 Aug 2024.